Yew Bio-Pharm Group, Inc. Deferred Income, Noncurrent
Yew Bio-Pharm Group, Inc. had Deferred Income, Noncurrent of $1.81 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredIncomeNoncurrent · last filed 2021-11-15
- 2021-09-30: Deferred Income, Noncurrent $1.81M.
- 2021-06-30: Deferred Income, Noncurrent $1.18M.
- 2021-03-31: Deferred Income, Noncurrent $1.17M.
- 2020-12-31: Deferred Income, Noncurrent $1.17M.
| Period end | Deferred Income, Noncurrent |
|---|---|
| 2021-09-30 | $1.81M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.18M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.17M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.17M 10-Q · filed 2021-11-15 |
| 2020-09-30 | $1.14M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.12M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $877.17K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $892.38K 10-K · filed 2021-03-30 |